The duration of effect of infliximab maintenance treatment in paediatric Crohn's disease is limited

C.I. de Bie, T.Z. Hummel, A. Kinderman, F.T.M. Kokke, G.M. Damen, C.M.F. Kneepkens, P.F. van Rheenen, J.J. Schweizer, J.H. Hoekstra, O.F. Norbruis, W.E. Tjon A Ten, A.C. Vreugdenhil, J.M. Deckers-Kocken, C.F.M. Gijsbers, J.C. Escher, L. de Ridder

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)243-250
JournalAlimentary Pharmacology and Therapeutics
Issue number2
Publication statusPublished - 2011

Cite this